John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
iShares China Large-Cap ETF
FXI
$4.24B
| $2.44M | 0.01% |
68,200
+59,610
| +694% | +$2.02M |
|
1552
DoubleVerify
DV
$2.06B
| $2.44M | 0.01% |
182,748
-848,270
| -82% | -$15.7M |
|
1553
nVent Electric
NVT
$24.5B
| $2.43M | 0.01% |
46,444
+2,845
| +7% | +$180K |
|
1554
Columbia Banking Systems
COLB
$8.64B
| $2.43M | 0.01% |
97,614
-52,877
| -35% | -$1.41M |
|
1555
HNI Corp
HNI
$3.6B
| $2.43M | 0.01% |
+54,860
| New | +$2.6M |
|
1556
Nike
NKE
$58.6B
| $2.42M | 0.01% |
38,121
-2,057,469
| -98% | -$151M |
|
|
MRC
1557
DELISTED
MRC Global
MRC
| $2.41M | 0.01% |
210,298
-151,678
| -42% | -$1.96M |
|
1558
Dover
DOV
$27.2B
| $2.41M | 0.01% |
13,739
-198,048
| -94% | -$38.1M |
|
1559
Ennis
EBF
$543M
| $2.41M | 0.01% |
119,848
+40,029
| +50% | +$831K |
|
1560
Mueller Water Products
MWA
$3.89B
| $2.41M | 0.01% |
94,707
-337,397
| -78% | -$8.46M |
|
1561
SunCoke Energy
SXC
$828M
| $2.4M | 0.01% |
261,260
-53,254
| -17% | -$511K |
|
1562
Willdan Group
WLDN
$1.3B
| $2.39M | 0.01% |
58,724
+33,247
| +130% | +$1.23M |
|
|
HEES
1563
DELISTED
H&E Equipment Services
HEES
| $2.38M | 0.01% |
25,119
-122,810
| -83% | -$10.7M |
|
1564
iShares ESG Screened S&P 500 ETF
XVV
$678M
| $2.38M | 0.01% |
55,600
-4,000
| -7% | -$181K |
|
1565
Park National Corp
PRK
$3.61B
| $2.37M | 0.01% |
+15,677
| New | +$2.57M |
|
1566
Arcutis Biotherapeutics
ARQT
$3.12B
| $2.37M | 0.01% |
151,569
+66,725
| +79% | +$940K |
|
1567
Crescent Capital BDC
CCAP
$394M
| $2.36M | 0.01% |
138,104
-55,876
| -29% | -$1.04M |
|
1568
RH
RH
$2.67B
| $2.36M | 0.01% |
10,073
-17,841
| -64% | -$6.18M |
|
|
TLN
1569
Talen Energy Corp
TLN
$14.7B
| $2.36M | 0.01% |
11,801
-95,863
| -89% | -$20.8M |
|
1570
Byline Bancorp
BY
$1.72B
| $2.36M | 0.01% |
90,046
+38,078
| +73% | +$1.07M |
|
1571
Arcus Biosciences
RCUS
$4.02B
| $2.34M | 0.01% |
298,424
+151,738
| +103% | +$1.76M |
|
1572
Barrett Business Services
BBSI
$819M
| $2.34M | 0.01% |
56,820
+48,698
| +600% | +$2.03M |
|
1573
Regenxbio
RGNX
$588M
| $2.34M | 0.01% |
326,708
-62,720
| -16% | -$467K |
|
|
SARO
1574
StandardAero Inc
SARO
$8.26B
| $2.33M | 0.01% |
87,579
+52,070
| +147% | +$1.39M |
|
1575
Mettler-Toledo International
MTD
$28.1B
| $2.33M | 0.01% |
1,975
-10,141
| -84% | -$13M |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.